FGEN and AZN Related Headlines

Go Back

Mar 1, 2021 04:06PM FibroGen (FGEN) announces FDA will hold an advisory committee meeting to review the new drug application for roxadustat
Mar 1, 2021 04:01PM FibroGen Provides Regulatory Update on Roxadustat
Dec 2, 2020 07:06AM FibroGen (FGEN) to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at ASH
Dec 2, 2020 07:00AM FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting
Oct 14, 2020 07:08AM FibroGen (FGEN) to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week
Oct 14, 2020 07:00AM FibroGen to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2020 Reimagined

FGEN and AZN Related Press Releases

Go Back

Mar 1, 2021 04:01PM FibroGen Provides Regulatory Update on Roxadustat
Dec 2, 2020 07:00AM FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting
Oct 14, 2020 07:00AM FibroGen to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2020 Reimagined

FGEN and AZN Related SEC Filings

Go Back